EWA
ATOS icon

EverSource Wealth Advisors’s Atossa Therapeutics ATOS Stock Holding History

EverSource Wealth Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Hold
0
– -$2 – 4286
2025
Q3 		– Sell
-15
Closed -$185 – 4318
2025
Q2 		$183 Buy
15
+8
+114% +$96 ﹤0.01% 4067
2025
Q1 		$71 Buy
7
+5
+250% +$61 ﹤0.01% 3866
2024
Q4 		$30 Buy
+2
New +$39 ﹤0.01% 3683

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

EverSource Wealth Advisors's ATOS Position: Q4 2025 in Review

EverSource Wealth Advisors held its Atossa Therapeutics (ATOS) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4286.

EverSource Wealth Advisors first reported a position in ATOS in Q4 2024 and has held it in 3 quarters since. The position peaked at $183 in Q2 2025. 67 funds tracked by Wall St. Rank hold ATOS as of Q4 2025.

  • EverSource Wealth Advisors held 0 shares of Atossa Therapeutics worth $0 as of Q4 2025.
  • EverSource Wealth Advisors left its Atossa Therapeutics share count unchanged in Q4 2025.
  • Atossa Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q4 2025, its #4286 holding.
  • EverSource Wealth Advisors first reported a position in Atossa Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • EverSource Wealth Advisors's Atossa Therapeutics position peaked at $183 in Q2 2025.
  • 67 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.